scispace - formally typeset
H

Hind M. Ewadh

Researcher at University of Babylon

Publications -  12
Citations -  154

Hind M. Ewadh is an academic researcher from University of Babylon. The author has contributed to research in topics: Wastewater & Environmental impact of pharmaceuticals and personal care products. The author has an hindex of 4, co-authored 8 publications receiving 80 citations. Previous affiliations of Hind M. Ewadh include National University of Malaysia.

Papers
More filters
Journal ArticleDOI

Phosphate removal from water using bottom ash: Adsorption performance, coexisting anions and modelling studies

TL;DR: This study employs industrial by-products (bottom ash (BA), as a cost-effective and eco-friendly alternative, to remediate water from phosphate in the presence of competitor ions (humic acid).
Journal ArticleDOI

Simultaneous removal of ibuprofen, organic material, and nutrients from domestic wastewater through a pilot-scale vertical sub-surface flow constructed wetland with aeration system

TL;DR: In this article, the authors analyzed the effectiveness of pilot-scale vertical subsurface flow constructed wetland (VSSFCW) planted with Scirpus grossus using an aeration system for simultaneous removal of ibuprofen, chemical oxygen demand (COD) and nutrients (NH3N, NO3-N, and PO4-P) from domestic wastewater.
Journal ArticleDOI

Occurrence of pharmaceuticals and personal care products in domestic wastewater, available treatment technologies, and potential treatment using constructed wetland: A review

TL;DR: In this article , the authors reviewed and highlighted the conventional treatment technologies involved for PPCPs removal in WWTPs as well as comparison with phytotechnology in the wastewater treatment field to combat the disconcerting occurrence of PPCP.
Journal ArticleDOI

Essential oils of rosemary as antimicrobial agent against three types of bacteria

TL;DR: The results proved that the EOs of rosemary were influential against bacteria and gave minimum inhibitory concentration (MIC) and can be used in the pharmaceutical industry for the production of new synthetic agents in the treatment of bacterial disease caused by these three types of bacteria.
Journal ArticleDOI

Optimized conditions for pharmaceuticals and personal care products removal by ozonation using response surface methodology

TL;DR: Evaluated the effectiveness of bacteriophages in removing Cefotaxime-resistant clinical Acinetobacter baumannii strains (CTX_RAB) in vitro and found they can be a good choice for clinical therapeutic use.